Atlas Trials

A Study Aimed at Assessing the Pharmacokinetic Properties of RGB-10 and Forsteo

Clinical trial NCT02223416 · COMPLETED

Trial details

NCT number
NCT02223416
Sponsor
Gedeon Richter Plc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Primary completion
2015-01-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.